FDA Label for Halaven
View Indications, Usage & Precautions
Halaven Product Label
The following document was submitted to the FDA by the labeler of this product Bsp Pharmaceuticals Spa. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Halaven®
(eribulin mesylate) Injection, for intravenous use
1 mg/2 mL (0.5 mg/mL)
Principal Display Panel - Shipper Label
Eisai Manufacturing Limited
Allegato DQA-035/XXXX
New Chemical Entity Demand Chain Unit European Knowledge Centre
Mosquito Way-Hatfield, Herts, AL 109SN
United Kingdom
HALAVEN®
(eribulin mesylate) Injection, for intravenous use- 0.5mg/ml, 2 ml
Store at 15° - 25°C (59° - 77°F). DO NOT FREEZE
QTY: 00XXX EXP: MM-YYYY LOT: F1XXYZZZ
(22) 900XXX MMYYYY F1XXYZZZ 7
NDC 43624-002-01
(0X) 50X XXXXX 00X X X0 XXX
Manufactured by : BSP Pharmaceuticals SpA-Latina Scalo, Italy.
* Please review the disclaimer below.